Three CEOs own up to biopharma’s bad reputation - STAT

Three CEOs own up to biopharma’s bad reputation - STAT

STAT Plus: ‘The industry has earned it’: Three CEOs own up to biopharma’s bad reputation

By KATE SHERIDAN

EMILIE PICKERING FOR STAT

CEOs from Bluebird Bio, Sage Therapeutics, and Turning Point Therapeutics owned up to biopharma's bad reputation at a STAT Summit panel.

READ MORE